Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 5 9 2020
medline: 13 11 2020
entrez: 4 9 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 is a novel cause of organ dysfunction in children, presenting as either coronavirus disease 2019 with sepsis and/or respiratory failure or a hyperinflammatory shock syndrome. Clinicians must now consider these diagnoses when evaluating children for septic shock and sepsis-associated organ dysfunction. The Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children provide an appropriate framework for the early recognition and initial resuscitation of children with sepsis or septic shock caused by all pathogens, including severe acute respiratory syndrome coronavirus 2. However, the potential benefits of select adjunctive therapies may differ from non-coronavirus disease 2019 sepsis.

Identifiants

pubmed: 32886460
doi: 10.1097/PCC.0000000000002553
pmc: PMC7597755
pii: 00130478-202011000-00045
doi:

Substances chimiques

Vasoconstrictor Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1031-e1037

Subventions

Organisme : NIGMS NIH HHS
ID : K23 GM110496
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Pediatr Crit Care Med. 2015 Jun;16(5):428-39
pubmed: 25647235
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
JAMA. 2020 May 26;323(20):2085-2086
pubmed: 32293646
Pediatr Crit Care Med. 2014 Jan;15(1):e17-26
pubmed: 24196006
Int Immunopharmacol. 2020 Jul;84:106560
pubmed: 32413736
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12526-12527
pubmed: 32398378
J Med Virol. 2020 Jul;92(7):819-823
pubmed: 32232979
Acad Med. 2014 Jan;89(1):114-20
pubmed: 24280846
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Pediatr Crit Care Med. 2013 Sep;14(7):686-93
pubmed: 23897242
Pediatrics. 1998 Aug;102(2):e19
pubmed: 9685464
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106
pubmed: 32032273
Intensive Care Med. 2020 Feb;46(Suppl 1):10-67
pubmed: 32030529
Lancet Child Adolesc Health. 2020 Jul;4(7):552-554
pubmed: 32437638
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288

Auteurs

Scott L Weiss (SL)

Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Mark J Peters (MJ)

UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital and NIHR Biomedical Research Centre London, London, United Kingdom.

Michael S D Agus (MSD)

Boston Children's Hospital and Harvard Medical School, Boston, MA.

Waleed Alhazzani (W)

McMaster University, Hamilton, ON, Canada.

Karen Choong (K)

McMaster University, Hamilton, ON, Canada.

Heidi R Flori (HR)

C.S. Mott Children's Hospital, Ann Arbor, MI.

David P Inwald (DP)

Addenbrooke's Hospital, Cambridge, London, United Kingdom.

Simon Nadel (S)

Addenbrooke's Hospital, Cambridge, London, United Kingdom.

Mark E Nunnally (ME)

New York University Langone Medical Center, New York, NY.

Luregn J Schlapbach (LJ)

The University of Queensland and Queensland Children's Hospital, Brisbane, QLD, Australia.

Robert C Tasker (RC)

Boston Children's Hospital and Harvard Medical School, Boston, MA.

Pierre Tissieres (P)

Paris Saclay University Hospitals, Assistance Publique Hopitaux de Paris, Paris, France.

Niranjan Kissoon (N)

British Columbia Children's Hospital, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH